Form 4: Cencora Director Dermot Mark Durcan Reports Acquisition of Common Stock

Director Dermot Mark Durcan reports acquisition of 986 shares of Cencora, Inc. common stock through a grant of restricted stock units.

Summary

• Dermot Mark Durcan, a director of Cencora, Inc., filed a Form 4 with the SEC.
• The report indicates that Durcan acquired 986 shares of Cencora's common stock on March 6, 2025.
• This acquisition was through a grant of restricted stock units, received for no consideration.
• The restricted stock units vest 100% on the first anniversary of the grant date.
• Following the transaction, Durcan beneficially owns 22,862 shares of Cencora common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.

Stakeholder Impact

• The acquisition of shares by a director may have a minor positive impact on shareholder confidence.

Key Dates